| Name | noggin |
| Description | The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNoggin is a secreted glycoprotein that plays a pivotal role during embryogenesis by antagonizing bone morphogenetic protein (BMP) signaling. Structural studies have revealed that Noggin binds BMP ligands—such as BMP‐7—by masking the receptor binding sites (thereby preventing BMP association with both type I and type II receptors), and genetic studies suggest that variants in NOG contribute to neural tube defects. Collectively, these observations highlight Noggin’s essential function in defining morphogen gradients and ensuring proper patterning during early development."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDuring skeletal morphogenesis and joint development, Noggin is indispensable in regulating BMP‐induced chondrogenesis and osteogenesis. Mutations in NOG have been uncovered in patients with proximal symphalangism and related disorders, where aberrant Noggin function leads to joint fusions and conductive hearing loss. Such findings underscore that finely tuned Noggin activity is required for normal joint segmentation and proper ossification patterns."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of bone regeneration and repair, Noggin acts as a critical regulator of BMP‐mediated osteoblastic differentiation. Its dynamic expression modulates osteogenesis in mesenchymal stem cells and during fracture healing, with studies demonstrating that suppression or altered levels of Noggin can either diminish or enhance osteogenic differentiation depending on cellular context. These data provide evidence that Noggin functions not only as an inhibitor of BMP signaling but also, in specific human settings, may be stimulatory for bone formation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn several cancer models, especially those involving bone metastasis, the level and timing of Noggin expression appear to greatly influence disease progression. In prostate and breast cancer metastases, for example, cancer cell–derived Noggin has been shown to suppress osteoblast activity, thereby favoring osteolytic lesion development and facilitating bone colonization. Moreover, in melanoma, aberrant upregulation of Noggin can confer resistance to the growth‐inhibitory effects of autocrine BMP7 signaling, thereby promoting tumor growth. These studies collectively suggest that a shift in the balance between BMP ligands and their inhibitor Noggin can have profound consequences for tumor development and metastatic potential."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent mechanistic studies have uncovered novel aspects of Noggin regulation. Activation of the extracellular calcium-sensing receptor, for instance, modulates NOT only BMP‐2 synthesis but also the local expression of Noggin in intestinal stromal cells, thereby influencing epithelial barrier repair. Additionally, advanced imaging and in silico analyses have revealed that spatial segregation and transcytosis of Noggin in human epiblasts are critical for its inhibitory activity on basolaterally delivered BMP4. Such insights have extended our understanding of how precise regulation of Noggin levels and localization is essential for both normal tissue homeostasis and the pathological alteration of BMP signaling in disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn craniofacial development, rare variants in NOG have been implicated in nonsyndromic cleft lip with or without cleft palate, further emphasizing Noggin’s nuanced role in regulating BMP activity during facial morphogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, studies have also identified a specialized population of Myo/Nog cells in the skin, which serve as the principal source of Noggin in hair follicles and wounds. These cells, by secreting Noggin, contribute to skin homeostasis and exhibit altered distribution in cutaneous tumors, identifying them as potential diagnostic and therapeutic targets in skin pathology."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Bärbel Felder, Karolin Stegmann, Almut Schultealbert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of BMP4 and its specific inhibitor NOG as candidates in human neural tube defects (NTDs)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.ejhg.5200875"}], "href": "https://doi.org/10.1038/sj.ejhg.5200875"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12404109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12404109"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jay Groppe, Jason Greenwald, Ezra Wiater, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis of BMP signalling inhibition by the cystine knot protein Noggin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature01245"}], "href": "https://doi.org/10.1038/nature01245"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12478285"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12478285"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Eva Chmielnicki, Abdellatif Benraiss, Aris N Economides, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenovirally expressed noggin and brain-derived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal ventricular zone."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.1554-03.2004"}], "href": "https://doi.org/10.1523/JNEUROSCI.1554-03.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14999064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14999064"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Murim Choi, Rolf W Stottmann, Yu-Ping Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The bone morphogenetic protein antagonist noggin regulates mammalian cardiac morphogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.RES.0000257780.60484.6a"}], "href": "https://doi.org/10.1161/01.RES.0000257780.60484.6a"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17218603"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17218603"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jian Wang, Tingting Yu, Zhigang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A New Subtype of Multiple Synostoses Syndrome Is Caused by a Mutation in GDF6 That Decreases Its Sensitivity to Noggin and Enhances Its Potency as a BMP Signal."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Bone Miner Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbmr.2761"}], "href": "https://doi.org/10.1002/jbmr.2761"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26643732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26643732"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "M Mangino, E Flex, M C Digilio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a novel NOG gene mutation (P35S) in an Italian family with symphalangism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.9016"}], "href": "https://doi.org/10.1002/humu.9016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11857750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11857750"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "David J Brown, Theresa B Kim, Elizabeth M Petty, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/342067"}], "href": "https://doi.org/10.1086/342067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12089654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12089654"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Sawako Masuda, Kazunori Namba, Hideki Mutai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A mutation in the heparin-binding site of noggin as a novel mechanism of proximal symphalangism and conductive hearing loss."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.04.015"}], "href": "https://doi.org/10.1016/j.bbrc.2014.04.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24735539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24735539"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Akira Ganaha, Tadashi Kaname, Yukinori Akazawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of two novel mutations in the NOG gene associated with congenital stapes ankylosis and symphalangism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jhg.2014.97"}], "href": "https://doi.org/10.1038/jhg.2014.97"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25391606"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25391606"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xiuhong Pang, Zhaoyan Wang, Yongchuan Chai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Novel Missense Mutation of NOG Interferes With the Dimerization of NOG and Causes Proximal Symphalangism Syndrome in a Chinese Family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Otol Rhinol Laryngol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0003489415582257"}], "href": "https://doi.org/10.1177/0003489415582257"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25888563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25888563"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Francois N K Kwong, Judith A Hoyland, Christopher H Evans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regional and cellular localisation of BMPs and their inhibitors' expression in human fractures."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Orthop (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00264-008-0691-z"}], "href": "https://doi.org/10.1007/s00264-008-0691-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19023570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19023570"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Marc Fajardo, Chuan-Ju Liu, Kenneth Egol "}, {"type": "b", "children": [{"type": "t", "text": "Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Orthop Relat Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11999-009-0981-9"}], "href": "https://doi.org/10.1007/s11999-009-0981-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19597895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19597895"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kening Song, Carola Krause, Songting Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.087197"}], "href": "https://doi.org/10.1074/jbc.M109.087197"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20048150"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20048150"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Chao Chen, Hasan Uludağ, Zhixiang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.24240"}], "href": "https://doi.org/10.1002/jcb.24240"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22740073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22740073"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Saeed M Hashimi "}, {"type": "b", "children": [{"type": "t", "text": "Exogenous noggin binds the BMP-2 receptor and induces alkaline phosphatase activity in osteoblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28597"}], "href": "https://doi.org/10.1002/jcb.28597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30887565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30887565"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Chun-Peng Xia, Tao Pan, Nan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sp1 promotes dental pulp stem cell osteoblastic differentiation through regulating noggin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Probes (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mcp.2019.101504"}], "href": "https://doi.org/10.1016/j.mcp.2019.101504"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31904417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31904417"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ruth Schwaninger, Cyrill A Rentsch, Antoinette Wetterwald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2007.051276"}], "href": "https://doi.org/10.2353/ajpath.2007.051276"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17200191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17200191"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Myriam Goldstein, Isaac Meller, Avi Orr-Urtreger "}, {"type": "b", "children": [{"type": "t", "text": "FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.20489"}], "href": "https://doi.org/10.1002/gcc.20489"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17696196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17696196"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Mei-Yu Hsu, Sherry A Rovinsky, Chiou-Yan Lai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/labinvest.2008.55"}], "href": "https://doi.org/10.1038/labinvest.2008.55"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18560367"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18560367"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hiu-Fung Yuen, Yuen-Piu Chan, Wai-Lok Cheung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prognostic significance of BMP-6 signaling in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2008.94"}], "href": "https://doi.org/10.1038/modpathol.2008.94"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18931653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18931653"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Andrey A Sharov, Andrei N Mardaryev, Tatyana Y Sharova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bone morphogenetic protein antagonist noggin promotes skin tumorigenesis via stimulation of the Wnt and Shh signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2009.090163"}], "href": "https://doi.org/10.2353/ajpath.2009.090163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19700758"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19700758"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Chiara Secondini, Antoinette Wetterwald, Ruth Schwaninger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0016078"}], "href": "https://doi.org/10.1371/journal.pone.0016078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21249149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21249149"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Hiu-Fung Yuen, Cian M McCrudden, Claire Grills, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2012.02252.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2012.02252.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22364398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22364398"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Maria Tarragona, Milica Pavlovic, Anna Arnal-Estapé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of NOG as a specific breast cancer bone metastasis-supporting gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.355834"}], "href": "https://doi.org/10.1074/jbc.M112.355834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22547073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22547073"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Riikka Laurila, Seppo Parkkila, Jorma Isola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression patterns of gremlin 1 and noggin in normal adult and tumor tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2013)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23826422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23826422"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Dinithi Peiris, Ivan Pacheco, Craig Spencer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00225.2006"}], "href": "https://doi.org/10.1152/ajpgi.00225.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17138967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17138967"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Joris Andrieux, Catherine Roche-Lestienne, Sandrine Geffroy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Genet Cytogenet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cancergencyto.2007.06.001"}], "href": "https://doi.org/10.1016/j.cancergencyto.2007.06.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17889703"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17889703"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Hye-Won Kang, Ronn Walvick, Alexei Bogdanov "}, {"type": "b", "children": [{"type": "t", "text": "In vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.08-127795"}], "href": "https://doi.org/10.1096/fj.08-127795"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19692649"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19692649"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Sabine Rudnik-Schöneborn, Tsutomu Takahashi, Sabine Busse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Facioaudiosymphalangism syndrome and growth acceleration associated with a heterozygous NOG mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.33387"}], "href": "https://doi.org/10.1002/ajmg.a.33387"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20503332"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20503332"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Sandra J Gutiérrez, Marilúz Gómez, Jorge A Rey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms of the noggin gene and mandibular micrognathia: a first approximation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Odontol Latinoam (2010)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20645637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20645637"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Nataly Urshansky, Karin Mausner-Fainberg, Eitan Auriel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuroimmunol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jneuroim.2010.10.007"}], "href": "https://doi.org/10.1016/j.jneuroim.2010.10.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21111488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21111488"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Sharon L Hyzy, Rene Olivares-Navarrete, Zvi Schwartz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BMP2 induces osteoblast apoptosis in a maturation state and noggin-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.24201"}], "href": "https://doi.org/10.1002/jcb.24201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22628200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22628200"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Tao Song, Jinna Shi, Qiang Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between NOGGIN and SPRY2 polymorphisms and nonsyndromic cleft lip with or without cleft palate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.36802"}], "href": "https://doi.org/10.1002/ajmg.a.36802"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25339627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25339627"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Tien Phan-Everson, Fred Etoc, Shu Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential compartmentalization of BMP4/NOGGIN requires NOGGIN trans-epithelial transport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.devcel.2021.05.003"}], "href": "https://doi.org/10.1016/j.devcel.2021.05.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34051144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34051144"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Taofik Al Chawa, Kerstin U Ludwig, Heide Fier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nonsyndromic cleft lip with or without cleft palate: Increased burden of rare variants within Gremlin-1, a component of the bone morphogenetic protein 4 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Birth Defects Res A Clin Mol Teratol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/bdra.23244"}], "href": "https://doi.org/10.1002/bdra.23244"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24706492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24706492"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jacquelyn Gerhart, Candace Hayes, Victoria Scheinfeld, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myo/Nog cells in normal, wounded and tumor-bearing skin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Dermatol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1600-0625.2012.01503.x"}], "href": "https://doi.org/10.1111/j.1600-0625.2012.01503.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22621191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22621191"}]}]}]}
|
| Synonyms | SYNS1, SYNS1A |
| Proteins | NOGG_HUMAN |
| NCBI Gene ID | 9241 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NOG has 8,538 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 104 datasets.
Click the + buttons to view associations for NOG from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by NOG gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NOG gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NOG gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NOG gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NOG gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NOG gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NOG gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving NOG protein from the Biocarta Pathways dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NOG gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NOG gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NOG gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NOG gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NOG gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NOG gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NOG gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with NOG gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with NOG gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NOG protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NOG protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NOG protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NOG gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NOG gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NOG gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NOG gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NOG gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving NOG gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with NOG gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NOG gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NOG gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NOG gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NOG gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NOG gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NOG gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NOG gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NOG gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NOG from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NOG gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NOG gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NOG gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NOG from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NOG gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NOG gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NOG gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NOG gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NOG gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NOG gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding NOG protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NOG gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NOG gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NOG gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NOG protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NOG gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NOG gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NOG gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of NOG gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NOG gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NOG gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NOG gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NOG gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NOG gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NOG gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NOG gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NOG protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NOG gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with NOG gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with NOG gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NOG gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by NOG gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NOG protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NOG gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NOG gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NOG gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving NOG protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving NOG protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NOG gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NOG gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NOG gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NOG protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NOG gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NOG gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NOG gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NOG gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with NOG gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NOG from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NOG gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NOG gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NOG protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NOG protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving NOG protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving NOG protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving NOG protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NOG gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NOG gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NOG gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of NOG gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of NOG gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NOG gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NOG gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NOG protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NOG protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NOG protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NOG protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving NOG protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving NOG protein from the WikiPathways Pathways 2024 dataset. | |